Purpose: Exaggerated pro-inflammatory reactions during the acute phase of Kawasaki disease (KD) suggest the role of immune dysregulation in the pathogenesis of KD. We investigated the profiles of T regulatory cells and their correlation with the clinical course of KD. Methods: Peripheral blood mononuclear cells were collected from 17 KD patients during acute febrile and subacute afebrile phases. T cells expressing CD4, CD25, and Foxp3 were analyzed using flow cytometry, and the results were correlated with the clinical course of KD. 
Foxp3
+ T cells among CD4 + T cells was significantly higher during the subacute afebrile phase than during the acute febrile phase ( 
Introduction
Kawasaki disease (KD) is a systemic vasculitis syndrome that features a high fever in infants and children. In Korea, 105 out of 100,000 people contract it, and the incidence rate ranks second in the world after Japan 1) . Despite numerous studies that have been carried out since it was reported first in 1967, the cause has not yet been established. As the causative pathogen has not been identified and excessive immune activation is observed in almost all patients during the acute phase of KD, we believe that abnormal immune activation from a nonspecific infection might be a possible cause.
The immune mechanism must maintain a balance between activation and suppression; specifically, when an infection occurs, the immune system is activated to remove the pathogen, but also regulated to preclude damage to autologous tissue. In the human body, various cells participate in the regulation of the immune response. Although CD25 and the forkhead family transcription factor (Foxp3) are the most representative markers for the T regulatory cells (Tregs), they are also expressed in activated T cells. . . As immunoregulatory abnormality may be related to the cause of KD, we investigated the profiles of Tregs in acute KD as well as the changes of relative ratio correlated to the clinical course of KD.
The purpose of this study was to investigate the roles of cells that express CD4, CD25, and Foxp3 markers in KD. Accordingly, the expression pattern was analyzed in patients with KD that showed excessive immune activation during the acute phase, and the changes were related to the progress of the disease.
Materials and methods

Materials
This study was performed on 17 patients diagnosed with KD between March and November, 2008 at Korea University Medical Center Ansan Hospital. The cases were characterized by a fever of more than 38.5℃ that continued for at least 5 days and was accompanied by at least four out of the following five symptoms: polymorphous rash, extremity changes, cervical lymphadenopathy, conjunctival injection, and distinctive oral manifestations. Eight patients satisfied all the diagnostic criteria. In the other nine patients where the clinical manifestations did not fulfill the diagnostic criteria and other diagnoses were excluded, symptoms that are frequently associated with KD and elevated inflammatory indices during the acute phase were considered to support the diagnosis of incomplete KD 8, 9) . These cases of incomplete KD were only included in this analysis if they showed a typical convalescent condition such as skin peeling. All 17 subjects were treated with intravenous immunoglobulin (IVIG, 2 g/kg) in addition to aspirin (50-80 mg/ kg/day). Echocardiography was performed usually at 7-10 days after onset of fever and thereafter at monthly intervals for at least 2 months. During this period, patients exhibiting any coronary abnormality, regardless of later resolution, were counted as having a coronary abnormality. In accordance with recommendations in a report from a subcommittee of the Japanese Research Committee on KD in 1984, a coronary artery abnormality is defined as a coronary artery diameter of at least 3 mm (those aged less than 5-years-old) or 4 mm (those aged 5 and older), and 1.5 times larger than the diameter of the closest blood vessel and an inner surface irregularity of the blood vessel 10) .
Methods
The peripheral blood of subjects was collected before the use of IVIG to bring down the fever and 2 days after defervescence, with the consent of their parents. After density-gradient centrifugation using a Ficoll centrifuges (Amersham Pharmacia, Biotech, Piscataway, NJ, USA), mononuclear cells were separated from peripheral blood. Mononuclear cells at a concentration of 1×10 6 /100 µ L phosphatebuffered saline were mixed with a cocktail of allophycocyanin (APC)-antihuman CD4 antibody and fluorescein isothiocyanate (FITC)-antihuman CD25 antibody (eBioscience, San Diego, CA, USA). The mixture was allowed to react at 4℃ for 30 min and was then rinsed with the phosphate-buffered saline. After 2 µ L of fixation and permeabilization solution was added, the mixture was allowed to further react at 4℃ for 30 min. Again, it was rinsed by the phosphate-buffered saline. In the same way, phycoerythin (PE)-antihuman Foxp3 antibody (eBioscience, San Diego, CA, USA) was administered, marked, and rinsed. The subjects were classified into four groups, i.e., a control group, a group of mononuclear cells marked by antihuman CD4 and CD25 antibodies, a group marked by the antihuman Foxp3 antibody, and a group marked by both antihuman CD4 and CD25 antibodies and antihuman Foxp3 antibodies. The subjects were then analyzed by the use of flow cytometry (FACSCalibur, CellQuest software, Becton Dickinson Immunocytometry System, San Jose, CA, USA) 11) . 1 ). For statistical analysis, SPSS (version 12.0, SPSS Inc., Chicago, IL, USA) was used with the paired t-test. Only cases in which the P value was less than 0.05 were considered to be significant, and the data were expressed in 'percentage (%)' or 'the mean±the standard deviation (SD)'.
Results
Characteristics of subjects
The average age of the 17 subjects was 30.8±15.8 months, and the ratio of males to females was 10:7. Their fevers were lowered after a single dose of IVIG (2 g/kg). After the administration of IVIG, the febrile phase lasted 1.4±1.1 days on the average, and the whole period of fever was 6.9±1.4 days. Two out of 17 subjects were diagnosed with coronary artery abnormalities, and on the echocardiographic followup performed 1 month later, both of them showed regression. The blood test showed that the hemoglobin and leukocyte levels decreased after defervescence but the platelet level increased. The erythrocyte sedimentation rate (ESR) increased but was not significant. C-reactive protein decreased remarkably after defervescence (Table 1) . (Fig. 2A) (Fig. 2D) . 
Foxp3
-T cells, which shows the balance between two groups, was determined (Fig. 3) . Fig. 3B and 3C, respectively). 12) , but on the other hand it has been reported that these cells are like Tregs from the viewpoint of phenotype, but are more like activated T cells on the basis of function 13, 14) . According to studies on systemic lupus erythematosus (SLE) patients, CD4 . In the process of reactivation, CD25 . Consequently, it is supposed that at the very least, CD25 
Discussion
CD25 and Foxp3 are the principal markers of Tregs but are simultaneously expressed in activated T cells; for that reason it is not easy to distinguish Tregs from activated T cells. It is not yet clear
Foxp3
-T cells was also heightened but was not significant. All of the subjects were treated with IVIG, and a series of changes were expected after defervescence. One working mechanism of IVIG is to bind to cells that secrete inflammatory cytokines and chemokines and suppress the secretion 17) . In addition, IVIG directly recovers the suppressive function of Tregs. IVIG binds more strongly to Tregs than to conventional T cells and induces an increase in Tregs both functionally and numerically 17, 18) . Treg levels increased in the spleen after IVIG, caused by the expansion of preexisting Tregs rather than de novo generation 18) . In addition to the induction of expression of Foxp3, as well as to the secretion of immunosuppressive TGF-β and IL-10, IVIG increases the proportion of CD4 + CD25
high Foxp3 + T cells 19) . Corticosteroid and infliximab, which are cited as alternative treatments for intractable KD, increase the level of Tregs in some cases 20, 21) . In the mean time, a therapy to directly induce Tregs in human patients suffering from allergies, by the use of specific 'probiotic' bacteria to build autoimmunity 22, 23) , could serve as a model for a possible alternative treatment for KD.
In many cases, serious coronary artery complications are re lated to a lengthy inflammatory condition. Brown et al.
4) who performed autopsies on eight children that died during the acute phase of KD reported an increase in the transmural infiltration of proinflammatory T cells such as CD8 + cytotoxic T cells and CD4 + T helper 1 cells. In other studies, coronary artery complications readily occurred upon increased cytokine secretion from T cell activation [24] [25] [26] . In our study, two subjects had coronary artery complications. Although these patients did not show a remarkable decrease of CD4 
